These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8862047)

  • 1. Irradiated uveal melanomas: cytopathologic correlation with prognosis.
    Char DH; Kroll SM; Miller T; Castro J; Quivey J
    Am J Ophthalmol; 1996 Oct; 122(4):509-13. PubMed ID: 8862047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of cytopathologic classification of melanocytic uveal tumors evaluated by fine-needle aspiration biopsy.
    Augsburger JJ; Corrêa ZM; Trichopoulos N
    Arq Bras Oftalmol; 2013; 76(2):72-9. PubMed ID: 23828465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of uveal melanoma cytopathologic sample retrieval in trans-scleral versus vitrectomy-assisted transvitreal fine needle aspiration biopsy.
    Chang MY; McCannel TA
    Br J Ophthalmol; 2014 Dec; 98(12):1654-8. PubMed ID: 24997179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation.
    Char DH; Castro JR; Quivey JM; Phillips TL; Irvine AR; Stone RD; Kroll S
    Ophthalmology; 1989 Dec; 96(12):1708-15. PubMed ID: 2695875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma.
    Harbour JW; Char DH; Kroll S; Quivey JM; Castro J
    Ophthalmology; 1997 Nov; 104(11):1785-92; discussion 1792-3. PubMed ID: 9373108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleral necrosis in patients with posterior uveal melanomas evaluated by transcleral fine needle aspiration biopsy and treated by 125I plaque.
    Correa ZM; Huth B; Augsburger JJ
    Arq Bras Oftalmol; 2018; 81(4):330-335. PubMed ID: 29995126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
    Sánchez-Tabernero S; García-Alvarez C; Muñoz-Moreno MF; Diezhandino P; Alonso-Martínez P; de Frutos-Baraja JM; López-Lara F; Saornil MA
    Am J Ophthalmol; 2017 Aug; 180():39-45. PubMed ID: 28572063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal melanoma. Growth rate and prognosis.
    Char DH; Kroll S; Phillips TL
    Arch Ophthalmol; 1997 Aug; 115(8):1014-8. PubMed ID: 9258223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.
    Char DH; Quivey JM; Castro JR; Kroll S; Phillips T
    Ophthalmology; 1993 Oct; 100(10):1547-54. PubMed ID: 8414414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications.
    Correa ZM; Augsburger JJ
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):131-5. PubMed ID: 24270974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma.
    Mishra KK; Quivey JM; Daftari IK; Weinberg V; Cole TB; Patel K; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):376-83. PubMed ID: 25841624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
    Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
    J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of melanoma cell type in uveal melanoma following treatment failure.
    Char DH; Miller T; Crawford JB
    Am J Ophthalmol; 2004 Oct; 138(4):543-6. PubMed ID: 15488778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
    Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
    Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 125I plaque therapy for uveal melanoma. Analysis of the impact of time and dose factors on local control.
    Quivey JM; Augsburger J; Snelling L; Brady LW
    Cancer; 1996 Jun; 77(11):2356-62. PubMed ID: 8635107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
    Kroll S; Char DH; Quivey J; Castro J
    Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.